What is Biogen's rituxan — after second gazyva threshold date?

Biogen (BIIB) reported rituxan — after second gazyva threshold date of 35.0% in Q1 2026.

How has Biogen's rituxan — after second gazyva threshold date changed year-over-year?

Biogen's rituxan — after second gazyva threshold date decreased by 0.0% year-over-year, from 35.0% to 35.0%.

What is the long-term trend for Biogen's rituxan — after second gazyva threshold date?

Over 2 years (2023 to 2025), Biogen's rituxan — after second gazyva threshold date has grown at a 0.0% compound annual growth rate (CAGR), from 140.0% to 140.0%.

What does rituxan — after second gazyva threshold date mean?

The profit-sharing terms that apply after a secondary product hits a specific milestone.

Products & Services · After Second GAZYVA Threshold Date

RITUXAN — After Second GAZYVA Threshold Date

Biogen RITUXAN — After Second GAZYVA Threshold Date remained flat by 0.0% to 35.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 35.0% to 35.0%. Over 2 years (FY 2023 to FY 2025), RITUXAN — After Second GAZYVA Threshold Date shows relatively stable performance with a 0.0% CAGR.

Analysis

StatementSegment

CategoryProfitability

SignalContext dependent

VolatilityStable

First reportedQ4 2018

Last reportedQ1 2026

How to read this metric

A shift in this metric reflects the transition to a new, contractually defined profit-sharing tier.

Detailed definition

This metric defines the profit-sharing or royalty structure applicable to a product collaboration following the achievem...

Peer comparison

Standard in multi-product collaboration agreements where profit splits evolve based on the success of the portfolio.

Metric ID: biib_segment_rituxan_after_second_gazyva_threshold_date

Historical Data

15 periods

	Q4 '21	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	35%	35%	35%	35%	35%	35%	35%	35%	35%	35%	35%	35%	35%	35%	35%
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	+0.0%	—	—	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%

Range35% – 35%

CAGR+0.0%

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Current Streak14+ quarters growth

Similar Metrics at Other Companies

Bristol-Myers SquibbBMY View metric

Natera, Inc.NTRA View metric

Bristol-Myers SquibbBMY View metric

Vertex PharmaceuticalsVRTX View metric

Bristol-Myers SquibbBMY View metric

Regeneron PharmaceuticalsREGN View metric

Frequently Asked Questions

What is Biogen's rituxan — after second gazyva threshold date?: Biogen (BIIB) reported rituxan — after second gazyva threshold date of 35.0% in Q1 2026.
How has Biogen's rituxan — after second gazyva threshold date changed year-over-year?: Biogen's rituxan — after second gazyva threshold date decreased by 0.0% year-over-year, from 35.0% to 35.0%.
What is the long-term trend for Biogen's rituxan — after second gazyva threshold date?: Over 2 years (2023 to 2025), Biogen's rituxan — after second gazyva threshold date has grown at a 0.0% compound annual growth rate (CAGR), from 140.0% to 140.0%.
What does rituxan — after second gazyva threshold date mean?: The profit-sharing terms that apply after a secondary product hits a specific milestone.